Submucous Plexus Neurons (Meissner's Plexus)

CLEC16A — C-Type Lectin Domain Family 16 Member A

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Submucous Plexus Neurons (Meissner's Plexus)</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Submucous Plexus Neurons (Meissner's Plexus)</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>

Overview

CLEC16A (C-Type Lectin Domain Family 16 Member A) is a surface receptor expressed predominantly on immune cells and increasingly recognized for its roles in autophagy, mitochondrial function, and cellular metabolism. Genetic variants in CLEC16A have been associated with multiple autoimmune and neurodegenerative diseases, making it a protein of significant research interest.

Introduction

The CLEC16A gene encodes a type I transmembrane protein with C-type lectin-like domains. It is located on chromosome 16p13.13, a region linked to various immune-mediated diseases. The protein is approximately 828 amino acids long with a molecular weight of around 93 kDa [@matesanz2007].

Structure

CLEC16A — C-Type Lectin Domain Family 16 Member A

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Submucous Plexus Neurons (Meissner's Plexus)</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Submucous Plexus Neurons (Meissner's Plexus)</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>

Overview

CLEC16A (C-Type Lectin Domain Family 16 Member A) is a surface receptor expressed predominantly on immune cells and increasingly recognized for its roles in autophagy, mitochondrial function, and cellular metabolism. Genetic variants in CLEC16A have been associated with multiple autoimmune and neurodegenerative diseases, making it a protein of significant research interest.

Introduction

The CLEC16A gene encodes a type I transmembrane protein with C-type lectin-like domains. It is located on chromosome 16p13.13, a region linked to various immune-mediated diseases. The protein is approximately 828 amino acids long with a molecular weight of around 93 kDa [@matesanz2007].

Structure

CLEC16A contains several distinctive features:

• C-type lectin-like domain (CTLD): Carbohydrate recognition
• Single transmembrane region: Membrane anchoring
• Cytoplasmic tail: Signaling motifs and internalization signals
• Immunoreceptor tyrosine-based activation/inhibition motifs (ITAM/ITIM)
• Fibronectin type III domains: Protein interactions

Cellular Functions

Autophagy Regulation

• Controls autophagosome formation
• Modulates mitophagy (mitochondrial autophagy)
• Regulates lysosomal function
• Essential for cellular homeostasis [@consortium2015]

Immune Cell Function

• T cell activation: Co-stimulatory signals
• B cell function: Antibody production
• NK cell activity: Cytotoxic function
• Dendritic cell maturation: Antigen presentation

Mitochondrial Quality Control

• Mitophagy induction
• Mitochondrial dynamics (fusion/fission)
• Metabolic reprogramming
• Reactive oxygen species management

Role in Neurodegeneration

Multiple Sclerosis

• CLEC16A variants increase MS risk
• Affects immune cell function
• May influence CNS autoimmunity
• Therapeutic target potential [@international2013]

Parkinson's Disease

• Linked to LRRK2 pathway interactions
• Mitochondrial dysfunction connections
• Autophagy impairment in dopaminergic neurons
• Genetic association studies ongoing

Alzheimer's Disease

• Possible roles in amyloid clearance
• Autophagy-lysosome pathway effects
• Neuroinflammation modulation

Type 1 Diabetes

• Strongest genetic association
• Pancreatic beta-cell function
• Autoimmune pathogenesis

Signaling Pathways

CLEC16A interfaces with multiple cascades:

• mTOR signaling: Autophagy regulation
• JAK-STAT pathway: Immune signaling
• NF-κB activation: Inflammatory responses
• AMPK pathway: Energy sensing

Therapeutic Implications

Targeting CLEC16A offers:

Genetic Associations

CLEC16A polymorphisms affect:

• Multiple sclerosis risk
• Type 1 diabetes susceptibility
• Parkinson's disease (suggestive)
• Autoimmune thyroid disease

Research Tools

• CLEC16A knockout mice
• Flow cytometry for surface expression
• Autophagy flux assays
• Mitochondrial function tests

Clinical Biomarkers

CLEC16A may serve as:

• Disease activity marker
• Treatment response predictor
• Risk stratification tool

Summary

CLEC16A bridges immune function and cellular homeostasis through its roles in autophagy and mitochondrial quality control. Its genetic associations with multiple diseases highlight its importance in human health.

Future Directions

• Developing CLEC16A-targeted therapies
• Understanding variant functional effects
• Biomarker validation studies
• [Neurons — Major brain cell type](/cell-types/neurons)](/entities/neurons)
• [Glia — Support cells in the brain](/genes/th)
• [Alzheimer's Disease — Related neurodegenerative disease](/genes/rel)
• [Parkinson's Disease — Related neurodegenerative disease](/genes/ar)

External Links

• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature

Pathway Diagram

The following diagram shows the key molecular relationships involving Submucous Plexus Neurons (Meissner's Plexus) discovered through SciDEX knowledge graph analysis: